T. Rowe Price Associates
OPGN

T. Rowe Price Associates’s OpGen, Inc OPGN Stock Holding History

T. Rowe Price Associates’s Portfolio OPGN Stock Details OPGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-115
Closed -$47K – 2879
2020
Q4 		$47K Hold
115
– – ﹤0.01% 2651
2020
Q3 		$49K Buy
+115
New +$51.2K ﹤0.01% 2547

Other funds holding OPGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bayesian Capital Management Brooklyn, New York $81.9M AUM 26.59% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

T. Rowe Price Associates's OPGN Position: Q1 2021 in Review

T. Rowe Price Associates sold out of OpGen, Inc (OPGN) in Q1 2021, closing a stake of 115 shares — an estimated $47K sold.

T. Rowe Price Associates first reported a position in OPGN in Q3 2020 and held it in 2 quarters. The position peaked at $49K in Q3 2020. 29 funds tracked by Wall St. Rank hold OPGN as of Q1 2021.

  • T. Rowe Price Associates reported no remaining OpGen, Inc position as of Q1 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 115 OpGen, Inc shares in Q1 2021, an estimated $47K.
  • T. Rowe Price Associates first reported a position in OpGen, Inc in Q3 2020 and held it in 2 quarters.
  • T. Rowe Price Associates's OpGen, Inc position peaked at $49K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held OpGen, Inc as of Q1 2021.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.